- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06945718
국부적으로 진행된 위암에 대한 D2 이상의 연장 된 림프절 절제술을 사용하여 복강경 위 절제술을 사용한 Indocyanine 녹색 트레이서의 임상 결과 (FUGES-30)
국부적으로 진행된 위암에 대한 D2 뇌파 림프절 절제술을 사용한 복강경 위 절제술을 사용하여 사용 된 디코 시아닌 녹색 추적기의 임상 결과에 대한 전향 적 무작위 대조 시험 (FUGES-30)
Taking patients with locally advanced gastric adenocarcinoma (cT2-4a, N-/+, M0) as the research subjects, to evaluate whether the clinical efficacy of laparoscopic beyond D2 regional lymph node dissection for gastric cancer with indocyanine green tracer is better or not.
연구 개요
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Mi Lin, phD
- 전화번호: 13459152658
- 이메일: silihuala@qq.com
연구 연락처 백업
- 이름: Hua-Long Zheng, phD
- 전화번호: 18359190587
- 이메일: 291167038@qq.com
연구 장소
-
-
Fujian
-
Fuzhou, Fujian, 중국, 350001
- 모병
- Fujian Medical University Union Hospital
-
연락하다:
- Changming Huang, M.D., Ph.D.
- 전화번호: +86-133-6591-0253
- 이메일: hcmlr2002@163.com
-
수석 연구원:
- Changming Huang, M.D., Ph.D.
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
Age from 18 to 75 years Primary gastric adenocarcinoma (papillary, tubular, mucinous, signet ring cell, or poorly differentiated) confirmed pathologically by endoscopic biopsy cT2-4a, N-/+, M0 at preoperative evaluation according to the AJCC Cancer Staging Manual, 8th Edition
설명
Inclusion Criteria:
Age from 18 to 75 years Primary gastric adenocarcinoma (papillary, tubular, mucinous, signet ring cell, or poorly differentiated) confirmed pathologically by endoscopic biopsy cT2-4a, N-/+, M0 at preoperative evaluation according to the AJCC Cancer Staging Manual, 8th Edition No distant metastasis, no direct invasion of pancreas, spleen or other adjacent organs in the preoperative examinations Performance status of 0 or 1 on the ECOG (Eastern Cooperative Oncology Group) scale ASA (American Society of Anesthesiology) class I to III Written informed consent
Exclusion Criteria:
Women during pregnancy or breast-feeding Severe mental disorder History of previous upper abdominal surgery (except for laparoscopic cholecystectomy) History of previous gastric surgery (including ESD/EMR for gastric cancer) Enlarged or bulky regional lymph node (diameter over 3cm) supported by preoperative imaging including enlarged or bulky lymph nodes in D3 region.
Other malignant disease within the past 5 years History of unstable angina or myocardial infarction within past six months History of cerebrovascular accident within past six months History of continuous systematic administration of corticosteroids within one month Requirement for simultaneous surgery for other disease Emergency surgery due to complication (bleeding, obstruction or perforation) caused by gastric cancer FEV1 (forced expiratory volume in one second)<50% of predicted values Diffuse invasive gastric cancer Tumors preoperatively confirmed to involve the squamocolumnar junction or duodenum History of an iodine allergy Patients who declined laparoscopic surgery
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: COHORT
- 시간 관점: PROSPECTIVE
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
laparoscopic gastrectomy with beyond D2 regional fluorescent lymph node dissection with ICG group
ICG with D2+ group |
dissect the lymph nodes outside the extent of D2 LN region. |
|
laparoscopic gastrectomy with D2 regional lymph node dissection with ICG group
ICG with D2 group |
dissect the lymph nodes outside the extent of D2 LN region. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
3-year disease free survival rate
기간: 3 years
|
Disease-free survival is calculated from the day of surgery to the day of recurrence or death |
3 years
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Total number of retrieved lymph nodes
기간: 30 days
|
Total number of retrieved lymph nodes |
30 days
|
|
Noncompliance rate of lymph node dissection
기간: 30 days
|
The LN dissection rate was determined by the number of patients in whom a LN station was harvested divided by the total number of patients who required retrieval at the corresponding LN station. Within the scope of D2 dissection, LN noncompliance was defined as the absence of LNs that should have been resected from > 1 LN station. |
30 days
|
|
Relationship between fluorescent lymph nodes in group A and total number of lymph nodes in group A
기간: 30 days
|
Relationship between the number of fluorescent lymph nodes in group A and total number of lymph nodes in group A |
30 days
|
|
Relationship between fluorescent lymph nodes in Group A and positive lymph nodes in Group A (positive rate)
기간: 30 days
|
The number of positive lymph nodes in fluorescent lymph nodes is divided by the number of total fluorescent lymph nodes in Group A (True positive rate). |
30 days
|
|
Relationship between fluorescent lymph nodes in Group A and negative lymph nodes in Group A (false positive rate)
기간: 30 days
|
The number of negative lymph nodes in fluorescent lymph nodes is divided by the number of total fluorescent lymph nodes in Group A (false positive rate). |
30 days
|
|
Relationship between non-fluorescent lymph nodes in Group A and negative lymph nodes in group A (negative rate)
기간: 30 days
|
The number of negative lymph nodes in not fluorescent lymph nodes is divided by the number of total not fluorescent lymph nodes in group A (True negative rate). |
30 days
|
|
Relationship between nonfluorescent lymph nodes in Group A and positive lymph nodes in Group A (false negative rate)
기간: 30 days
|
The number of positive lymph nodes in not fluorescent lymph nodes is divided by the number of total not fluorescent lymph nodes in Group A (false negative rate). |
30 days
|
|
Relationship between fluorescent lymph nodes in group B and total number of lymph nodes in group B
기간: 30 days
|
Relationship between the number of fluorescent lymph nodes in group B and total number of lymph nodes in group B |
30 days
|
|
Relationship between fluorescent lymph nodes in Group B and positive lymph nodes in Group B (positive rate)
기간: 30 days
|
The number of positive lymph nodes in fluorescent lymph nodes is divided by the number of total fluorescent lymph nodes in Group B (True positive rate). |
30 days
|
|
Relationship between fluorescent lymph nodes in Group B and negative lymph nodes in Group B (false positive rate)
기간: 30 days
|
The number of negative lymph nodes in fluorescent lymph nodes is divided by the number of total fluorescent lymph nodes in Group A (false positive rate). |
30 days
|
|
Relationship between non-fluorescent lymph nodes in Group B and negative lymph nodes in group B (negative rate)
기간: 30 days
|
The number of negative lymph nodes in not fluorescent lymph nodes is divided by the number of total not fluorescent lymph nodes in group B (True negative rate). |
30 days
|
|
Relationship between nonfluorescent lymph nodes in Group B and positive lymph nodes in Group B (false negative rate)
기간: 30 days
|
The number of positive lymph nodes in not fluorescent lymph nodes is divided by the number of total not fluorescent lymph nodes in Group B (false negative rate). |
30 days
|
|
Number of metastatic lymph nodes
기간: 30 days
|
Number of metastatic lymph nodes |
30 days
|
|
Metastasis rate of lymph nodes
기간: 30 days
|
Metastasis rate of lymph nodes |
30 days
|
|
Postoperative complications
기간: 30 days
|
Postoperative complications were evaluated within 30 days following surgery. These postoperative complications include gastrointestinal-related complications, incision-related complications, respiratory complications, cardiovascular and cerebrovascular complications, urinary system complications, infection complications, embolism complications, and other complications. The grading of postoperative complications adopts the Clavien-Dindo classification. |
30 days
|
|
Mortality rates
기간: 30 days
|
Patient died during hospitalization. |
30 days
|
|
3-year overall survival rate
기간: 3 years
|
3-year overall survival rate |
3 years
|
|
3-year recurrence pattern
기간: 3 years
|
3-year recurrence pattern |
3 years
|
|
Postoperative recovery course
기간: 30 days
|
Time to first flatus after surgery, time to first ambulation after surgery, time to first liquid diet after surgery, time to first semi-liquid diet after surgery, length of hospital stay after surgery. |
30 days
|
|
The incidence of intraoperative complications
기간: 30 days
|
Intraoperative complications were defined as bleeding due to named vessel injury, injury to visceral organs, mechanical factor-related problems, cardiopulmonary dysfunction due to hypercapnia, and other complications |
30 days
|
|
Inflammatory and immune response
기간: 7 days
|
the values of hemoglobin, prealbumin, albumin, C-reactive protein, and white blood cell count from peripheral blood before the operation and on postoperative day 1, 3, 5 are recorded. |
7 days
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Chang-Ming Huang, Prof., Fujian Medical University Union Hospital
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .